Author: Ms. Neha Goel
Volume: 01
First Online: 31 August 2024
Pages: 139-149
DOI: https://doi-ds.org/doilink/09.2024-56912271/SproutPublication/book/Ch.12/Pharmacovigilance

Effective communication in pharmacovigilance is essential for ensuring the safe use of medicines and maintaining public trust in healthcare systems. It involves the timely and accurate dissemination of information about drug safety to various stakeholders, including healthcare professionals, regulatory authorities, pharmaceutical companies, and the general public. Key aspects of pharmacovigilance communication include the reporting of adverse drug reactions (ADRs), the issuance of safety alerts and updates, and the education of healthcare providers and patients about the risks and benefits of medications. Transparent and clear communication helps to promptly address safety concerns, guide clinical practice, and inform regulatory decisions. This process also involves managing the public’s perception of drug safety, particularly during crises or when new risks are identified. By ensuring that all stakeholders are well-informed, pharmacovigilance communication plays a critical role in enhancing patient safety, supporting informed decision-making, and fostering a culture of safety in the use of medicines.

Keywords: Healthcare Providers, Regulatory Authorities, Pharmaceutical Companies, Public Trust, Risk Communication